The Endocrinology and Metabolism Research Training Program (T32) at Duke University Medical Center consists of an interactive matrix of clinical and basic science divisions, departments and centers. The mission of this program is to develop the next generation of biomedical researchers in Endocrinology and Metabolism. The trainees will be either board- eligible or certified physicians who have trained in Internal Medicine or Pediatrics, or non- physician science graduates who wish to pursue careers in endocrine/metabolic research. The Endocrinology T32 has a long history of training successful investigators in diabetes, metabolic bone disease, and other areas of endocrine/metabolic research. A substantial majority (83% over the past 10 years who are not still in training) are in academic positions at major medical centers across the US and abroad. Most are in positions with substantial research components, supported by federal, foundation, or industry grants, and the remainder have significant teaching responsibilities. They have almost 300 publications since they began their Endocrinology research training. The program includes training opportunities in clinical, translational, and basic research. Seven different research training modules have been designed to allow the trainee exposure to some of the most important areas of endocrine/metabolic research today, and afford the opportunity for training with outstanding scientists and mentors. These modules range from those solely devoted to basic science (Nuclear Receptor Signaling and Pharmacology;G Protein-Coupled Receptors) to those with basic and clinical/translational arms (Diabetes, Obesity and Nutrient Metabolism;Metabolic Components of Cardiovascular Disease;Bone and Mineral Metabolism;Pediatric Endocrinology;Women's Health). Trainees are jointly mentored by basic and clinical research scientists to promote broader understanding of research concepts, and also attend didactic teaching programs designed to provide the tools necessary for success in a research career. Training is aimed at promoting the understanding, design and use of biochemical, physiological and molecular biological approaches to endocrine and metabolic problems, as well as proficiency in laboratory and clinical investigation techniques. Individuals who complete the program will be capable of independent investigation and able to translate research accomplishments into significant advances with clinical relevance.

Public Health Relevance

Diseases such as diabetes, osteoporosis, obesity, and high cholesterol are critical, and growing, public health problems in the United States as well as the rest of the world. Diabetes and its complications alone is responsible for every fifth health care dollar spent in the US, by some estimates. In our state of North Carolina, 29.4% of the population is obese, and 9.6% have diabetes. Furthermore, the impact on minority populations is disproportionately high. There is a nationwide shortage of endocrinologists, and endocrine researchers are in particularly short supply. More must be trained. The Duke University Medical Center T32 Research Training Program in Endocrinology and Metabolism has a mission to recruit and train outstanding physicians and other medical scientists for careers in endocrine/metabolic research in an outstanding multifaceted environment.

National Institute of Health (NIH)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Digestive Diseases and Nutrition C Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Tantibhedhyangkul, J; Hawkins, K C; Dai, Q et al. (2014) Expression of a mitochondrial progesterone receptor in human spermatozoa correlates with a progestin-dependent increase in mitochondrial membrane potential. Andrology 2:875-83
Mayer, S B; Jeffreys, A S; Olsen, M K et al. (2014) Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes. Diabetes Obes Metab 16:90-3
Coppola, Anna; Wenner, Brett R; Ilkayeva, Olga et al. (2013) Branched-chain amino acids alter neurobehavioral function in rats. Am J Physiol Endocrinol Metab 304:E405-13
Lee, Richard H; Weber, Thomas; Colón-Emeric, Cathleen (2013) Comparison of cost-effectiveness of vitamin D screening with that of universal supplementation in preventing falls in community-dwelling older adults. J Am Geriatr Soc 61:707-14
Bohinc, Brittany; Michelotti, Gregory; Diehl, Anna Mae (2013) Hedgehog signaling in human medullary thyroid carcinoma: a novel signaling pathway. Thyroid 23:1119-26
Fonseca, Vivian; McDuffie, Roberta; Calles, Jorge et al. (2013) Determinants of weight gain in the action to control cardiovascular risk in diabetes trial. Diabetes Care 36:2162-8
Corsino, Leonor; Yancy, William S; Samsa, Gregory P et al. (2011) Physician characteristics as predictors of blood pressure control in patients enrolled in the hypertension improvement project (HIP). J Clin Hypertens (Greenwich) 13:106-11
Li, Josephine H; Lao, Xiang Qian; Tillmann, Hans L et al. (2010) Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection. Hepatology 51:1904-11
Lee, Richard; Weber, Thomas J (2010) Disorders of phosphorus homeostasis. Curr Opin Endocrinol Diabetes Obes 17:561-7
Cox, Mary E; Williams, Laura L; Lien, Lillian F (2010) Pheochromocytoma in pregnancy. Endocr Pract 16:337-8

Showing the most recent 10 out of 31 publications